lehman
brothers
said
analyst
jerry
brimeyer
raised
rating
algos
pharmaceutical
buy
venture
cited
positive
results
phase
ii
clinical
trial
confirming
morphidex
superior
efficacy
morphine
treating
pain
analyst
said
research
note
morphidex
combination
morphine
nmda
antagonist
demonstrated
60
percent
improved
analgesic
comparison
morphine
separate
clinical
trials
said
company
phase
iii
trials
expected
file
food
drug
administration
late
1997
approval
planned
1998
